Online Database of Chemicals from Around the World

2,3-Dihydro-3-methyl-2-benzothiazolethione
[CAS# 2254-94-6]

List of Suppliers
Shanghai T&W Pharmatech Co., Ltd. China Inquire  
+86 (21) 6155-1611
6155-1413
6155-1420
contact@trustwe.com
Chemical manufacturer since 2007
chemBlink standard supplier since 2008
Hangzhou Molcore Biopharmatech Co., Ltd. China Inquire  
+86 (571) 8102-5280
sales@molcore.com
QQ chat
Chemical manufacturer since 2010
chemBlink standard supplier since 2017
Achemica Switzerland Inquire  
+41 (24) 466-2929
contact@achemica.com
Chemical manufacturer since 2010
Chem Service, Inc. USA Inquire  
+1 (610) 692-3026
info@chemservice.com
Chemical manufacturer since 1962
Complete supplier list of 2,3-Dihydro-3-methyl-2-benzothiazolethione
Identification
Name 2,3-Dihydro-3-methyl-2-benzothiazolethione
Synonyms 3-Methylbenzothiazoline-2-thione; N-Methylbenzothiazoline-2-thione; NSC 66551
Molecular Structure CAS # 2254-94-6, 2,3-Dihydro-3-methyl-2-benzothiazolethione, 3-Methylbenzothiazoline-2-thione, N-Methylbenzothiazoline-2-thione, NSC 66551
Molecular Formula C8H7NS2
Molecular Weight 181.28
CAS Registry Number 2254-94-6
EC Number 218-852-9
Properties
Solubility Practically insoluble (0.049 g/L) (25 ºC), Calc.*
Density 1.39±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 92-94 ºC**
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
** Akiba, Kinya; Bulletin of the Chemical Society of Japan 1979, V52(1), P156-9.
Safety Data
Hazard Symbols symbol   Xi    Details
Risk Codes R36/37/38    Details
Safety Description S26;S37/39    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2H319
Specific target organ toxicity - single exposureSTOT SE3H335
SDS Available
Market Analysis Reports
List of Reports Available for 2,3-Dihydro-3-methyl-2-benzothiazolethione
Related Products
5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one oxime  1,4-Dihydro-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1-(1-methylethyl)spiro[5H-indazole-5,4'-piperidin]-7(6H)-one  2,3-Dihydro-2-methyl-1H-benz[e]indene-1-one  2,3-Dihydro-3-methyl-1,2-benzisothiazole 1,1-dioxide  1,3-Dihydro-5-methyl-2H-1,4-benzodiazepin-2-one  2,3-Dihydro-alpha-methyl-5-benzofuranethanamine hydrochloride  2,3-Dihydro-N-methyl-7-benzofuranmethanamine  (4R)-3,4-Dihydro-5-methyl-2H-1-benzopyran-4-amine  (4S)-3,4-Dihydro-6-methyl-2H-1-benzopyran-4-amine  2,3-Dihydro-5-methyl-4H-1-benzopyran-4-one  3,4-Dihydro-4-methyl-2H-1,4-benzoxazine-6-methanamine  N-[4-[2,3-Dihydro-1-(2-methylbenzoyl)-1H-indol-5-yl]-5-methyl-2-thiazolyl]-1,3-benzodioxole-5-acetamide  (2R,4S)-rel-3,4-Dihydro-2-(3-methyl-2-buten-1-yl)-4-[(methylthio)methoxy]-1(2H)-naphthalenone  1a,7a-Dihydro-1a-(3-methyl-2-butenyl)naphth[2,3-b]oxirene-2,7-dione  4,5-Dihydro-2-[(3-methyl-2-buten-1-yl)thio]thiazole  6,7-Dihydro-5-methyl-5(H)-cyclopentapyrazine  5,7-Dihydro-5-methyl-6H-dibenz[b,d]azepin-6-one  N-(5,11-Dihydro-5-methyl-10H-dibenz[b,f]azepin-10-ylidene)-methanamine ethanedioate (1:1)  2-[[3,4-Dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-piperidinylamino]-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile  N-[2-(3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine